Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

Ann Intern Med. 1995 Apr 15;122(8):586-91. doi: 10.7326/0003-4819-122-8-199504150-00005.

Abstract

Objective: To identify predictors of a long-term response to interferon-alpha therapy in chronic hepatitis C and to determine whether hepatitis C virus (HCV) was eradicated in patients with chronic hepatitis C who had a long-term response to therapy.

Design: A retrospective analysis.

Setting: In- and outpatient liver clinic of a municipal hospital in Japan.

Patients: 47 patients with chronic hepatitis C who responded to interferon-alpha were divided into two groups: 22 patients with a long-term response (serum aminotransferase levels remained normal for > 1 year after therapy) and 25 patients with a short-term response (serum aminotransferase levels increased again after therapy).

Measurements: Genotyping of HCV, titers of HCV RNA in liver and serum samples (using the reverse transcriptase-polymerase chain reaction), histologic activity index, and liver histologic tests during and 1 year after therapy.

Results: Among the 22 long-term responders, HCV RNA was no longer detectable in liver and serum samples of 21 (95%) at the end of therapy and remained undetectable in the serum of 20 (91%) and in the liver of 19 (86%) 1 year after therapy. Liver histologic tests improved substantially immediately after therapy and 1 year after therapy in the long-term responders; however, 18 (82%) of these patients still had mild, chronic hepatitis. Among the 25 short-term responders, HCV RNA was still detected in the liver of 19 (76%) and in the serum of 9 (36%) at the end of therapy. Multivariate logistic regression analysis showed that the persistent presence of hepatic HCV RNA at the end of therapy was the strongest predictor of relapse.

Conclusion: These findings suggest that HCV infection was eradicated in most of the long-term responders to interferon-alpha therapy because HCV RNA could no longer be detected in their serum and liver samples and because a significant improvement gradually occurred in their liver histologic results. The persistent presence of hepatic HCV RNA at the end of therapy was the most important predictor of relapse.

MeSH terms

  • Adult
  • Alanine Transaminase / metabolism
  • Base Sequence
  • Biomarkers / analysis
  • Biomarkers / blood
  • Chronic Disease
  • Female
  • Hepacivirus / genetics*
  • Hepatitis C / pathology
  • Hepatitis C / therapy*
  • Hepatitis C / virology
  • Humans
  • Interferon-alpha / therapeutic use*
  • Liver / pathology
  • Logistic Models
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • RNA, Viral / analysis*
  • RNA, Viral / blood
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Interferon-alpha
  • RNA, Viral
  • Alanine Transaminase